These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 8041988

  • 21. [Therapeutic results in the treatment of small cell bronchial cancer: experience of the EORTC Lung Cancer Working Party (Belgium)].
    Sculier JP.
    Bull Cancer; 1987; 74(5):565-8. PubMed ID: 2825858
    [Abstract] [Full Text] [Related]

  • 22. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.
    Schmitz N, Kloess M, Reiser M, Berdel WE, Metzner B, Dorken B, Kneba M, Trumper L, Loeffler M, Pfreundschuh M, Glass B, German High-Grade Non Hodgkin's Lymphoma Study Group (DSHNHL).
    Cancer; 2006 Jan 01; 106(1):136-45. PubMed ID: 16331635
    [Abstract] [Full Text] [Related]

  • 23. Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: a cancer and leukemia group B study (CALGB 9062).
    Miller AA, Rosner GL, Ratain MJ, Hollis DR, Green MR, Schilsky RL.
    Clin Cancer Res; 1997 May 01; 3(5):719-25. PubMed ID: 9815741
    [Abstract] [Full Text] [Related]

  • 24. [Combination chemotherapy and radiotherapy in small cell carcinoma of the lung].
    Yoshida S, Ogata T, Homma T, Kikuchi K, Masuda H, Matsuoka T, Sugiyama K, Noguchi Y, Yoneda S, Fukuda T.
    Gan To Kagaku Ryoho; 1986 Jul 01; 13(7):2331-6. PubMed ID: 3015041
    [Abstract] [Full Text] [Related]

  • 25. Random prospective study cyclophosphamide, doxorubicin, and methotrexate (CAM) combination chemotherapy versus single-agent sequential chemotherapy in non small cell lung cancer.
    Einhorn LH, Williams SD, Stevens EE, Bond WH, Chenoweth L.
    Cancer Treat Rep; 1982 Dec 01; 66(12):2005-11. PubMed ID: 6291763
    [Abstract] [Full Text] [Related]

  • 26. Comparison of cisplatin-paclitaxel combination versus cisplatin-etoposide in patients with small-cell lung cancer: a Phase III study.
    Dimitroulis J, Rapti A, Stathopoulos GP, Rigatos S, Stathopoulos J, Koutantos J, Athanasiadis A, Tsikritsaki K, Karaindros D, Katis K, Antoniou D, Toumbis M, Giamboudakis P.
    Oncol Rep; 2008 Oct 01; 20(4):879-84. PubMed ID: 18813830
    [Abstract] [Full Text] [Related]

  • 27. A randomized clinical trial comparing concurrent and alternating thoracic irradiation for patients with limited small cell lung carcinoma. "Petites Cellules" Group.
    Lebeau B, Urban T, Bréchot JM, Paillotin D, Vincent J, Leclerc P, Meekel P, L'Her P, Lebas FX, Chastang C.
    Cancer; 1999 Oct 15; 86(8):1480-7. PubMed ID: 10526276
    [Abstract] [Full Text] [Related]

  • 28. The addition of cisplatin to cyclophosphamide-doxorubicin-etoposide combination chemotherapy in the treatment of patients with small cell lung carcinoma: A randomized study of 457 patients. "Petites Cellules" Group.
    Urban T, Chastang C, Lebas FX, Duhamel JP, Adam G, Darse J, Bréchot JM, Lebeau B.
    Cancer; 1999 Dec 01; 86(11):2238-45. PubMed ID: 10590363
    [Abstract] [Full Text] [Related]

  • 29. Use of cisplatin, cyclophosphamide, vincristine, and doxorubicin for the treatment of non-small cell lung cancer.
    Lindgren D, Cadman E, Erichson R, Grann V, Sachs K.
    Cancer Treat Rep; 1984 Sep 01; 68(9):1159-61. PubMed ID: 6090015
    [Abstract] [Full Text] [Related]

  • 30. [Nerve conduction velocity following high-dose vincristine in the treatment of small cell bronchial cancer].
    Eich F, Emser W, Sybrecht GW.
    Pneumologie; 1990 Feb 01; 44 Suppl 1():574-5. PubMed ID: 2164202
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Multidisciplinary treatment for small cell lung cancer].
    Saijo N, Eguchi K, Shimizu E, Shinkai T, Tominaga K, Takahashi K, Sasaki Y, Seki S.
    Gan To Kagaku Ryoho; 1984 Mar 01; 11(3):474-9. PubMed ID: 6322700
    [Abstract] [Full Text] [Related]

  • 34. [Adriamycin in the combined chemotherapy of small-cell lung cancer].
    Perevodchikova NI, Bychkov MB, Ausekar BV.
    Antibiotiki; 1983 Aug 01; 28(8):628-32. PubMed ID: 6314882
    [Abstract] [Full Text] [Related]

  • 35. [Results of a sequential polychemotherapy (adriamycin, vincristine, cyclophosphamide, methotrexate) in small-cell and undifferentiated bronchial cancer].
    Taytard A, Chomy P, Courty G, Gachie JP, Roquain J.
    Rev Fr Mal Respir; 1980 Aug 01; 8(3):225-32. PubMed ID: 6314444
    [Abstract] [Full Text] [Related]

  • 36. Etoposide (VP-16) containing combination chemotherapy for treatment of patients with small cell lung cancer.
    Behera D, Jindal SK, Sharma SC.
    Indian J Chest Dis Allied Sci; 1995 Aug 01; 37(1):15-9. PubMed ID: 16892733
    [Abstract] [Full Text] [Related]

  • 37. Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent.
    Pujol JL, Carestia L, Daurès JP.
    Br J Cancer; 2000 Jul 01; 83(1):8-15. PubMed ID: 10883661
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Treatment of small cell lung cancer: experience at Maharaj Nakhon Chiang Mai Hospital.
    Thongprasert S, Jiemsripong K, Phothirat C, Atikachai B.
    J Med Assoc Thai; 1991 May 01; 74(5):253-6. PubMed ID: 1664446
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.